EMMN Emmi AG
Emmi AG, together with its subsidiaries, manufactures and sells dairy products in Switzerland, North and South America, the rest of Europe, Africa, and the Asia Pacific. The company offers dairy products comprising milk, cream, and butter; cheese, including raclette and fondue; fresh products consisting of yogurts, yogurt drinks, kefir products, and desserts; fresh cheese, which consists of mozzarella, protein-rich cottage cheese, goat's milk fresh cheese, and goat's cheese curds; powders and concentrates, including milk powder; and other products and services, such as ready-to-drink coffee and trading business. It sells its products under the Emmi Caffè Latte, Gerber, Emmi Energy Milk High Protein, Kaltbach, Emmi Jogurt Pur, Emmi High Protein Water, Aktifit, Luzerner, Emmi Benecol, Emmi Good Day, Le petit chevrier, Emmi Raclette, Tonis mozzarella, Pierrot Ice Cream, and beleaf brands. The company also exports its products. The company was founded in 1907 and is headquartered in Lucerne, Switzerland. Emmi AG is a subsidiary of ZMP Invest AG.…
Industry Peers
Packaged FoodsKey Statistics
About Emmi (SWX: EMMN)
›
Emmi (SWX: EMMN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 12,831 employees.
The shares were at 982.00 CHF on 19 November 2026, up 38.0% over 52 weeks. Its 52-week range is 700.00 CHF to 998.00 CHF: the price is 1.6% below the high and 40.3% above the low.
At a market capitalisation of 5.25B CHF, it trades at 22.8 times trailing earnings and 20.3 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, so EMMN is valued in line with them. It pays a dividend yielding 1.77% (it pays out 41% of its earnings), against a median of 3.60% among the dividend payers in that peer group.
Emmi reports return on equity of 21.0%, an operating margin of 7.1% and revenue up 2.2% year over year.
Its debt exceeds its cash by 883.47M CHF, a debt-to-equity ratio of 1.21. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 6 analysts cover the stock; their mean price target of 963.67 CHF is 1.9% below the current price. The next earnings report is expected on 3 March 2027.